Body Composition Methods in Adults with Type 2 Diabetes or at Risk for T2D: a Clinical Review

被引:15
|
作者
Sneed, Nadia Markie [1 ]
Morrison, Shannon A. [2 ]
机构
[1] Univ Alabama Birmingham, Sch Nursing Off Res & Scholarship, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Sch Nursing, Dept Family Community Hlth & Syst, Birmingham, AL USA
关键词
Body composition; Type 2 diabetes risk; Type; 2; diabetes; Prediabetes; Clinical review; HOMEOSTASIS MODEL ASSESSMENT; ADIPOSE-TISSUE DISTRIBUTION; INSULIN-RESISTANCE; CARDIOMETABOLIC RISK; CONSENSUS STATEMENT; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; ABDOMINAL FAT; OLDER-ADULTS; MUSCLE MASS;
D O I
10.1007/s11892-021-01381-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of ReviewThe aim of this study is to summarize anthropometric and advanced methods used to assess body composition in adults diagnosed with type 2 diabetes (T2D) or at risk for T2D that provide clinically relevant information about T2D disease-related complications or risk factors.Recent FindingsAnthropometry is commonly used in clinical settings; however, provides unreliable estimates of fat mass, fat-free mass, and body fat distribution for metabolic health assessments compared to advanced techniques such as bioelectrical impedance analysis (BIA), dual-energy x-ray absorptiometry (DXA), computerized tomography (CT), and magnetic resonance imaging (MRI). Few studies report the clinical use of anthropometric and advanced body composition methods that identify T2D disease-related complications or T2D risk factors.SummaryAnthropometry, BIA, DXA, CT, and MRI were used to estimate body adiposity and distribution, visceral and subcutaneous adipose tissue depots, and skeletal muscle mass. Review findings indicate that these methods were capable of identifying clinically relevant T2D disease-related complications such as sarcopenia and T2D risk factors such as obesity or regional adiposity. However, estimates were often sex and race/ethnicity specific warranting cross-validation of these methods in broader populations with T2D or risk for T2D prior to clinical implementation.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Type 2 diabetes (T2D) and quantitative trait association analysis of a Finnish sample with SNPs previously reported to be associated with T2D
    Bonnycastle, LL
    Willer, CJ
    Jackson, AU
    Conneely, KN
    Mohlke, KL
    Scott, LJ
    Narisu, N
    Chines, PS
    Erdos, MR
    Valle, TT
    Buchanan, TA
    Bergman, RN
    Tuomilehto, JA
    Watanabe, RM
    Boehnk, M
    Collins, FS
    DIABETES, 2005, 54 : A43 - A43
  • [42] Effect of Ketogenic Diet with Weight Maintenance in Type 2 Diabetes (T2D)
    Merovci, Aurora
    Finley, Brittany
    Chavez, Alberto
    Hansis-Diarte, Andrea A.
    Neppala, Sivaram
    Tripathy, Devjit
    Defronzo, Ralph A.
    DIABETES, 2023, 72
  • [43] Properties of Beta-Cells in Human Type 2 Diabetes (T2D)
    Marselli, Lorella
    Suleiman, Mara
    Bugliani, Marco
    Syed, Farooq
    Olimpico, Francesco
    Scatena, Fabrizio
    Focosi, Daniele
    Filipponi, Franco
    Boggi, Ugo
    Marchetti, Piero
    DIABETES, 2013, 62 : A567 - A567
  • [44] The Effect of Type 2 Diabetes on Body Composition of Older Adults
    Koster, Annemarie
    Schaap, Laura A.
    CLINICS IN GERIATRIC MEDICINE, 2015, 31 (01) : 41 - +
  • [45] Neural Network to Identifying Type 2 Diabetes (T2D) Progression Subphenotypes
    Huang, Yu
    Fan, Zhengkang
    Donahoo, William T.
    Guo, Jingchuan
    Bian, Jiang
    DIABETES, 2024, 73
  • [46] Outcomes of Type 2 Diabetes (T2D) Clustering Replicated in the DEVOTE Trial
    Kahkoska, Anna R.
    Hachmann-Nielsen, Elise
    Klein, Klara
    Kongsbak, Kristine G.
    Kvist, Kajsa
    Buse, John B.
    DIABETES, 2019, 68
  • [47] Children with Type 2 Diabetes (T2D) Have Altered Arginine Metabolism
    Tosur, Mustafa
    Hsu, Jean W.
    Deen, Saima
    Uysal, Serife
    Astudillo, Marcela
    Redondo, Maria J.
    Jahoor, Farook
    Balasubramanyam, Ashok
    DIABETES, 2022, 71
  • [48] Mechanisms of the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes (T2D)
    Muscelli, Elza
    Casolaro, Arturo
    Gastaldelli, Amalia
    Mari, Andrea
    Seghieri, Giuseppe
    Chen, Yu
    Alba, Maria
    Holst, Jens
    Ferrannini, Ele
    DIABETES, 2011, 60 : A267 - A267
  • [49] Effectiveness of a screening program of type 2 diabetes (T2D) in Primary Care, and long-term incidence of T2D in Spain
    Gabriel, R.
    Vazquez-Fernandez, A.
    Marques, P.
    Novella, B.
    Moreno, S.
    Vega, S.
    Gonzalvez, L.
    Arranz, M.
    Melero, M. C.
    Montero Herrero, M. R.
    Acosta Vergara, T.
    Tuomilehto, J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [50] Dapagliflozin (DAPA) in Patients with Type 2 Diabetes (T2D) and Mixed Dyslipidemia
    Bays, Harold E.
    Sartipy, Peter
    Xu, John
    Langkilde, Anna Maria
    Sjostrom, C. David
    DIABETES, 2016, 65 : A306 - A306